Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation

Nonalcoholic fatty liver disease (NAFLD) has become one of the public health problems globally. The occurrence of NAFLD is usually accompanied by a series of chronic metabolic diseases, with a prevalence rate is 25.24% among adults worldwide. Therefore, NAFLD seriously affects the quality of life in...

Full description

Bibliographic Details
Main Authors:	Jingxuan Zhou, Nanhai Zhang, Adil Aldhahrani, Mohamed Mohamed Soliman, Liebing Zhang, Feng Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	nonalcoholic fatty liver disease puerarin lipid accumulation oxidative stress inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.956688/full

Similar Items

A Review of the Effects of Puerarin on Glucose and Lipid Metabolism in Metabolic Syndrome: Mechanisms and Opportunities
by: Xiaoxuan Jing, et al.
Published: (2022-12-01)

Puerarin Prevents Bisphenol S Induced Lipid Accumulation by Reducing Liver Lipid Synthesis and Promoting Lipid Metabolism in C57BL/6J Mice
by: Zi-Yao Wu, et al.
Published: (2023-08-01)

Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
by: Mengmeng Yang, et al.
Published: (2023-11-01)

Ameliorated biomechanical properties of carotid arteries by puerarin in spontaneously hypertensive rats
by: Xiaoxia Fang, et al.
Published: (2021-06-01)

Absolute oral bioavailability and disposition kinetics of puerarin in female rats
by: Tosapol Anukunwithaya, et al.
Published: (2018-05-01)

Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases
by: Yan-Xi Zhou, et al.
Published: (2021-12-01)

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5
by: Zhaoyi Li, et al.
Published: (2024-07-01)

Effect of puerarin on human choriocarcinoma cells
by: Bao Lidao, et al.
Published: (2015-04-01)

Enzymatic Synthesis of Novel and Highly Soluble Puerarin Glucoside by <i>Deinococcus geothermalis</i> Amylosucrase
by: Hsiou-Yu Ding, et al.
Published: (2022-06-01)

Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway
by: Xiang-Peng Zeng, et al.
Published: (2021-06-01)

Effects and mechanisms of puerarin against neuroblastoma: insights from bioinformatics and in vitro experiments
by: Xiaohui Sui, et al.
Published: (2024-07-01)

Puerarin attenuates LPS-induced renal inflammatory response of mice
by: FENG Na, TANG Jie, HE Xi-ju, TIAN Zong-ying, SHI Dan-dan, YU Jing-jing
Published: (2022-11-01)

Puerarin—an isoflavone with beneficial effects on bone health
by: Bartosz Kulczyński, et al.
Published: (2021-12-01)

Lignin/Puerarin Nanoparticle-Incorporated Hydrogel Improves Angiogenesis through Puerarin-Induced Autophagy Activation
by: Pan Y, et al.
Published: (2023-09-01)

Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
by: Guoyou Zhang, et al.
Published: (2019-10-01)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
by: Bo Zhang, et al.
Published: (2023-08-01)

Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes
by: Xueling Li, et al.
Published: (2020-02-01)

Puerarin protects rat liver and kidney against cadmium-induced oxidative stress
by: JICANG WANG, et al.
Published: (2019-09-01)

Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways
by: Wang J, et al.
Published: (2021-08-01)

Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults
by: Yiting Liu, et al.
Published: (2022-01-01)

Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice
by: Ji-Won Noh, et al.
Published: (2022-01-01)

Puerarin: a hepatoprotective drug from bench to bedside
by: Yi-Xiang He, et al.
Published: (2024-10-01)

Puerarin Protects from Methotrexate Induced Hepatotoxicity in AML-12 Cells
by: Melek AKINCI, et al.
Published: (2023-09-01)

Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression
by: Junfa Yang, et al.
Published: (2021-08-01)

Puerarin alleviates inflammation and pathological damage in colitis mice by regulating metabolism and gut microbiota
by: Yixin Zou, et al.
Published: (2023-10-01)

Effects of puerarin on the Akt signaling pathway in bovine preadipocyte differentiation
by: Jinyan Yun, et al.
Published: (2020-01-01)

Puerarin@Chitosan composite for infected bone repair through mimicking the bio-functions of antimicrobial peptides
by: Liping Ouyang, et al.
Published: (2023-03-01)

Effects of puerarin on the reduction of glucose and promotion of overall health in acutely stressed Chinook salmon, Oncorhynchus tshawytscha (Actinopterygii: Salmoniformes: Salmonidae)
by: M.R. Hossain, et al.
Published: (2013-06-01)

Protective effects of puerarin on liver tissue in Salmonella-infected chicks: a proteomic analysis
by: Yu Lu, et al.
Published: (2024-01-01)

Puerarin Exerts Protective Effects on Wear Particle-Induced Inflammatory Osteolysis
by: Chao Yang, et al.
Published: (2019-10-01)

Puerarin as potential treatment in diabetic retinopathy
by: Mohammad Fathalipour, et al.
Published: (2020-03-01)

Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats
by: Wenyao Yang, et al.
Published: (2022-07-01)

Improving complexation of puerarin with kudzu starch by various ultrasonic pretreatment: Interaction mechanism analysis
by: Yuheng Li, et al.
Published: (2024-12-01)

Coexisting flavonoids and administration route effect on pharmacokinetics of Puerarin in MCAO rats
by: Li Pengyue, et al.
Published: (2020-07-01)

Effects of Puerarin on Bone Density in Rats and Mice: A Meta-analysis
by: HU Jinhua, et al.
Published: (2024-04-01)

Metabolomic and microbiome analysis of the protective effects of Puerarin against Salmonella Enteritidis Infection in chicks
by: Yu Lu, et al.
Published: (2023-11-01)

Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice
by: Wenjing Tao, et al.
Published: (2019-11-01)

Puerarin prevents cadmium-induced mitochondrial fission in AML-12 cells via Sirt1-dependent pathway
by: Xue-Mei Wan, et al.
Published: (2022-12-01)

Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII
by: Xindong Chen, et al.
Published: (2022-08-01)

Effects of Puerarin on Cardiac Differentiation and Ventricular Specialization of Murine Embryonic Stem Cells
by: Ying Cheng, et al.
Published: (2013-09-01)